Sign up to save your podcasts
Or
Share 258: Pharma vs. PBMs, Sarepta at the FDA, & a bold idea gone awry
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
258: Pharma vs. PBMs, Sarepta at the FDA, & a bold idea gone awry
We discuss a Senate hearing that put major pharma CEOs in the same room with the middlemen they love to blame for rising drug prices, with mixed results. We also explain what is a massive week for Sarepta Therapeutics, the FDA, and the future of gene therapies for rare diseases, plus the latest news in the life sciences.
View all episodes
By STAT
4.5
303303 ratings
We discuss a Senate hearing that put major pharma CEOs in the same room with the middlemen they love to blame for rising drug prices, with mixed results. We also explain what is a massive week for Sarepta Therapeutics, the FDA, and the future of gene therapies for rare diseases, plus the latest news in the life sciences.
More shows like The Readout Loud
View all
Planet Money
30,974 Listeners
a16z Podcast
1,014 Listeners
Odd Lots
1,774 Listeners
How I Built This with Guy Raz
30,265 Listeners
The Daily
111,044 Listeners
KFF Health News' 'What the Health?'
482 Listeners
The Long Run with Luke Timmerman
123 Listeners
Tradeoffs
386 Listeners
Biotech 2050 Podcast
60 Listeners
Business Of Biotech
88 Listeners
BioCentury This Week
31 Listeners
Raising Health
146 Listeners
Biotech Hangout
11 Listeners
Ground Truths
45 Listeners
Money Stuff: The Podcast
368 Listeners